Breast Journal Vol 16 Sept - Oct Supplement

A New Era in the Diagnosis and Treatment of Breast Cancer
Tabár L and Dean PB
S2-4
Abstract only


Challenges in the Interpretation of Breast Core Biopsies
Corben AD et al.
S5-9
Abstract only


Lobular Carcinoma, Not Only a Classic
Brogi E et al.
S10-4
Abstract only


Trends in the Surgical Treatment of Breast Cancer.
Morrow M
S17-9
Abstract only


Oncoplastic Surgery: The Evolution of Breast Cancer Treatment
De Lorenzi F
S20-1
Abstract only


Breast Cancer in Pregnancy.
Rovera F et al.
S22-5
Abstract only


The role of Micrometastatic Disease in Sentinel Lymph Node in Breast Cancer
Rovera F et al.
S26-8
Abstract only


Predictors of Loco-Regional Recurrence and Cancer-Related Death after Breast Cancer Surgery
Rausei S et al.
S29-33
Abstract only


Radiotherapy for Breast Cancer in the 21st Century
Powell S
S34-8
Abstract only


Capecitabine in Breast Cancer: The Issue of Cardiotoxicity During Fluoropyrimidine Treatment
Molteni LP et al
S45-8
Abstract only


The Surgical Management of Ductal Carcinoma In Situ
Kumar S and Sacchini V
S49-52
Abstract only

Breast Journal Vol 16 Iss 5 Sept - Oct 2010

Axillary Ultrasound Assessment in Primary Breast Cancer: An Audit of 653 Cases.
P Mills et al.
p460-3
Abstract only


Breast Reduction in the Irradiated Breast: Evidence for the Role of Breast Reduction at the Time of Lumpectomy.
B M Parrett et al.
p498-502
Abstract only


Survival in Breast Cancer Patients Undergoing Immediate Breast Reconstruction.
S Agarwal et al.
p503-9
Abstract only


Lobular Neoplasia of the Breast.
R Venkitaraman
p519-28
Abstract only


Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome.
S Dawood et al
p529-32
Abstract only


The Extent of Axillary Lymph Node Clearance Required Following Detection of Sentinel Node Micrometastases.
M F Dillon et al.
p533-6
Abstract only


Pleomorphic Liposarcoma of the Breast Mimicking Breast Abscess in a 19-Year-Old Postpartum Female: a Case Report and Review of the Literature.
K C Nadipati et al
p537-40
Abstract only


Imaging of Dermatofibrosarcoma Protuberans of Breast.
S Liu et al.
p541-3
Abstract only

Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma.

Prospective matched-pair comparison of outcome after treatment for lobular and ductal breast carcinoma.
The British journal of surgery, Jul 2008, vol. 95, no. 7
p. 827-33
Mhuircheartaigh-J-Ni, Curran-C, Hennessy-E, Kerin-M-J.
Abstract
BACKGROUND: Whether the prognosis of invasive lobular carcinoma is different from that of other invasive breast cancers is controversial. The aim of this study was to compare the outcome in age- and stage-matched patients with lobular carcinoma and those with invasive breast cancer, and in particular to compare predictors of outcome. METHODS: Data were obtained from a prospectively maintained database that included patients who had breast surgery for invasive cancer. Patients were matched for International Union Against Cancer stage and age at diagnosis within 5 years. Two patients with invasive ductal carcinoma were matched to each patient with invasive lobular carcinoma. RESULTS: There was no significant difference between invasive ductal and lobular carcinomas in terms of overall survival. Oestrogen receptor (ER)-positive invasive ductal carcinoma had a better prognosis than ER-positive invasive lobular carcinoma (P = 0.011). Similarly, ER-negative invasive ductal carcinoma was associated with worse survival than ER-negative invasive lobular carcinoma (P = 0.054). CONCLUSION: These results suggested that the differences in outcome between invasive ductal and lobular carcinomas may be determined by ER status.